Table 2.
Occurrence Events and Prognosis.
| n =152 | % | |
|---|---|---|
| IDFS Event | 30 | 20% |
| Patients with invasive disease, first recurrence | 27 (18%) | 18% |
| (Local/regional recurrence) | (6) | (4%) |
| (Distant recurrence) | (19) | (13%) |
| (Contralateral recurrence) | (0) | |
| (Second primary neoplasm) | (5) | (3%) |
| Death from any cause without invasive disease | 3 | 2% |
| Median time to IDFS event, months（range） | 60 (3.8119) | |
| DRFS event | 19 | 13% |
| Median time to DRFS event, months（range） | 34.7 (3.9105) | |
| Bone | 11 | 7% |
| Liver | 5 | 3% |
| Lung | 5 | 3% |
| Brain | 1 | 0.7% |
| Lymph node | 3 | 2% |
| Pleura | 0 | |
| Central nervous system | 0 | |
| Soft tissue | 0 | |
| Skin | 0 | |
| Peritoneum | 0 | |
| Other | 1 | 0.7% |
| Death from any cause without | 3 | 2% |
| Distant recurrence | ||
| Final Outcomes | ||
| Survival | 143 | 91% |
| Death | 9 | 6% |
| (breast cancer) | (5) | (3%) |
IDFS, invasive-disease-free survival; DRFS, distant-relapse-free survival